Asia Pacific Cancer Tissue Diagnostics Market : Business Opportunities, Competition & Key Companies, Current Trends and Challenges Upto 2027

"The Asia Pacific Cancer tissue diagnostics market is expected to reach US$ 730.09 Mn in 2027 from US$ 410.78 Mn in 2018. The market is estimated to grow with a CAGR of 6.9% from 2020-2027."

The growth of the market is driven by factors such as the rising number of cancer patients in the Asia Pacific and technological advancements and product launches in Asian countries whereas the lack of resources and awareness for cancer screening and treatment in poor/ less developed countries is likely to have a negative impact on the growth of the market in the coming years.
Developing countries in Asia have limited or fewer healthcare resources and hence use different strategies to diagnose different types of cancer. In developing poor countries, most of the population relies on the public healthcare systems as the healthcare infrastructures are poor in these countries. Despite advancements in the pharmaceuticals and treatment procedures, cancer is diagnosed in the advanced stages in developing countries as early detection or diagnosis, and treatment is not efficiently promoted.

Many of the low- and middle-income countries (LMICs) in Asia have very poor healthcare services, and the cancer burden is substantial in these countries. Despite the increasing burden of cancer, the disease is still a low priority in healthcare planning and expenditure in most of the Asian LMICs.

To Remain 'Ahead' Of Your Competitors, Request for a Sample Here@ http://bit.ly/38OwtRo

Companies Mentioned

o F. Hoffmann-La Roche Ltd
o Thermo Fisher Scientific Inc.
o Bio Rad Laboratories Inc.
o Abbott
o Enzo Life Sciences, Inc.
o Agilent Technologies, Inc.
o Cancer Genetics Inc.
o Merck KGaA (Sigma-Aldrich Co. LLC)
o Danaher Corporation
o Abcam plc.

Furthermore, South Asian women show lower uptake of breast screening services, especially those from lower socioeconomic groups. Screening rates are low in South Asian populations because they have poor knowledge and awareness of cancer, low community awareness, poor communication between patients and healthcare professionals, and limited access to cancer health services. Thus cancer mortality is high in LMICs as compared with high-income countries (HICs).

There has been rise in cancer incidence and mortality rates in China, making cancer the leading cause of death since 2010 in the country. Much of the rising burden is due to population growth, aging population, and socio-demographic changes. As per data revealed by the WHO, an approximate 4.3 million new cases of cancer were detected as well as 2.9 million cancer deaths were recorded in the country during the year 2018. The prevalence of cancer, coupled with various technological advancements for detection is anticipated to fuel the growth of the market in China during the forecast period.

For In-Depth Competitive Analysis, Buy Now @ http://bit.ly/2w6C9c7

ASIA PACIFIC CANCER TISSUE DIAGNOSTICS - MARKET SEGMENTATION

-By Test Type

o Immunohistochemical Tests

o Breast Cancer
o Colorectal Cancer
o Prostate Cancer
o Stomach Cancer
o Others

o In Situ Hybridization Tests

o Breast Cancer
o Lung Cancer
o Bladder Cancer
o Others

-By Country

o China
o Japan
o India
o Australia
o South Korea

Reasons to Buy:

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cancer tissue diagnostics market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific cancer tissue diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com

Pune, India

About The Insight Partners :

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.